{
  "pmcid": "6781206",
  "sha256": "e20fe3175bbe8a1401a5b443b0804f4853afa7404d3d1f8d57714c0573cb06ca",
  "timestamp_utc": "2025-11-09T22:52:00.868622+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.377286571296725,
    "reading_ease": 31.052196585140763,
    "word_count": 197
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Ultrasound-Guided Greater Occipital Nerve Block with Botulinum Toxin for Chronic Occipital Headache"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "54 patients aged 18-85 with chronic occipital headache were randomised into two groups"
      },
      "Participants": {
        "score": 2,
        "evidence": "54 patients aged 18-85 with chronic occipital headache were randomised into two groups: bupivacaine (BUP, n=27) and botulinum toxin (BTX, n=27)."
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised into two groups: bupivacaine (BUP, n=27) and botulinum toxin (BTX, n=27)."
      },
      "Objective": {
        "score": 1,
        "evidence": "This randomised controlled trial evaluated the long-term efficacy of ultrasound-guided greater occipital nerve (GON) block using botulinum toxin in patients with chronic occipital headache."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was pain reduction measured by the Visual Analogue Scale (VAS) over 24 weeks."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a closed-envelope technique, and allocation was concealed."
      },
      "Blinding": {
        "score": 3,
        "evidence": "Blinding was maintained for patients, clinicians, and outcome assessors."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "54 patients aged 18-85 with chronic occipital headache were randomised into two groups"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The VAS scores at 4, 8, and 24 weeks were significantly lower in the BTX group compared to the BUP group (p<0.05)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported in either group."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "The trial was registered under number 20110021167"
      },
      "Funding": {
        "score": 1,
        "evidence": "funded by Hanyang University Guri Hospital."
      }
    },
    "total_score": 20,
    "max_score": 25
  }
}